NCT05822089

Intraindividual Comparison of EMO IOLs

Comparison of Visual Outcomes of Enhanced Monofocal Intraocular Lenses

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 461 (estimated)
• Sponsor: Medical University of Vienna · Academic / Other
• Sex: All
• Age: 50 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

The investigational devices are approved intraocular lenses (IOLs) intended to be implanted after phacoemulsification in individuals suffering from age-related cataract with the need of cataract surgery. Cataract surgery with precedent bilateral randomized IOL implantation will be performed in subjects who have signed an informed consent form. Postoperative examinations will be implemented in accordance with the approved investigational plan.

Conditions

• Age Related Cataracts

Interventions

Type	Name	Description
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of a monofocal IOL (ZCB00) vs. an enhanced monofocal IOL (ICB00)
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of a monofocal IOL (Sensar 1 AAB00) vs. an enhanced monofocal IOL (ICB00)
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of a monofocal IOL (Vivinex XY1) vs. an enhanced monofocal IOL (Vivinex impress)
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of an enhanced monofocal IOL (Vivinex impress) in both eyes
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of an enhanced monofocal IOL (EnVista) vs. an enhanced monofocal IOL (LuxSmart)
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of an extended depth of focus IOL (Acrysof IQ Vivity) in both eyes if low to moderate irregular astigmatism is observed
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of an extended depth of focus IOL (IC-8 Apthera) in one eye if irregular astigmatism is observed
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of a monofocal IOL (EnVista) vs. an enhanced monofocal IOL (EnVista Aspire)
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of an enhanced depth of focus IOL (PureSee) in both eyes
PROCEDURE	phacoemulsification and intraocular lens implantation	bilateral cataract surgery including phacoemulsification in individuals suffering from age-related cataract and intraocular lens implantation of a monofocal IOL (Vivinex XY1) in both eyes or a monofocal IOL (Vivinex XC1) in both eyes

Timeline

• Start date: 2021-12-13
• Primary completion: 2026-12-31
• Completion: 2026-12-31
• First posted: 2023-04-20
• Last updated: 2025-12-05

Locations

1 site across 1 country: Austria